Welcome to the e-CCO Library!

P765: A description of inflammatory bowel disease patients’ beliefs in their medications, in comparison with patients with other chronic conditions
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Marín-Jiménez*1, D. Orozco-Beltrán2, J. Toro3, M. J. Galindo4, B. Juliá5, L. Cea-Calvo6

Created: Friday, 22 February 2019, 9:41 AM
P765: Role of C-reactive protein kinetics after surgery for Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Carvello*, F. Di Candido, G. Fiorino, S. Danese, A. Spinelli

Created: Thursday, 21 February 2019, 9:14 AM
P765: Tolerating infliximab therapeutic drug monitoring without anti-drug antibodies – an argument for drug intolerant assays?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Carlson, S.(1);Evgeniou, V.(1)*;Kok, K.(1);
Created: Friday, 14 July 2023, 11:12 AM
P765: Transcriptome of intestinal epithelial barrier genes in the colonic mucosa from patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fonseca Camarillo G., Iturriaga Goyon E., Yamamoto Furusho J.K.

Created: Wednesday, 20 February 2019, 10:36 AM
P766 ABO blood groups and ulcerative colitis: A hospital-based study in central Taiwan
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H.C. Lai1, J.W. Chou2, K.S. Cheng2, Y.H. Wu2, Y.Y. Tsai3, T.W. Chen4

Created: Thursday, 30 January 2020, 10:12 AM
P766: Combination therapy of fresh fecal microbial transplantation and antibiotics for ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ishikawa D., Takahashi M., Haga K., Shibuya T., Osada T., Watanabe S.

Created: Wednesday, 20 February 2019, 10:36 AM
P766: Practical application of evidence-based dietary therapy into inflammatory bowel disease care shows high patient satisfaction, compliance, and efficacy. The Delectable Program
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Russell, E.(1,2);Trakman, G.(1,2,3);Hamilton, A.L.(1,2);Wilson-O'Brien, A.(1,2);Hendricks, N.(4);Simmance, N.(4);Thompson, E.(4);Niewiadomski, O.(1)*;Kamm, M.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P766: Quantum Blue® fCAL extended POC user performance evaluation
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Fellay1, M. Drzewicka2, E. Burri3, M.-E. Ueberschlag4, A. Ritz4, J. Wieland4, M. Schneider4*

Created: Thursday, 21 February 2019, 9:14 AM
P767 Prevalence and incidence rates of inflammatory bowel disease among First Nations: Population-based evidence from Saskatchewan, Canada
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.N. Peña-Sánchez1, D. Jennings1, J.A. Osei1, M. Andkhoie2, C. Brass3, G. Bukassa Kazadi4, S. Fowler5, M. Johnson-Jennings6, X. Lu7, J.D. Marques Santos1, L. Porter8, R. Porter9, C.L. Quintin10, R. Sanderson11, U. Teucher12, IBD Among Indigenous Peoples Research Group

Created: Thursday, 30 January 2020, 10:12 AM
P767: Intestinal ultrasonography predicts short term clinical remission in patients with moderate-to-severe ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zorzi, F.(1);De Cristofaro, E.(1);Abreu, M.T.(2);Montesano, L.(1);Cuccagna, E.(1);Essofi, S.(1);Biancone, L.(1);Monteleone , G.(1);Calabrese, E.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P767: Non-adherence behaviours of patients with inflammatory bowel disease and other chronic conditions. Relationship with experience with healthcare and beliefs in medications
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Marín-Jiménez*1, D. Orozco-Beltrán2, J. Toro3, M. J. Galindo4, B. Juliá5, L. Cea-Calvo6

Created: Friday, 22 February 2019, 9:41 AM
P767: Quantum Blue® infliximab POC user performance evaluation
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Fellay1, M. Kopertowska-Majchrzak2, E. Burri3, M.-E. Ueberschlag4, A. Ritz4, T. Schuster4*

Created: Thursday, 21 February 2019, 9:14 AM
P767: The FIT trial: anti-inflammatory dietary intervention effects on the intestinal microbiota
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sabino J.*1, Vieira-Silva S.2,3, Machiels K.4, Joossens M.2,3,5, Falony G.2,3, Ferrante M.4, Van Assche G.4, Van Der Merwe S.6, Matthys C.7, Raes J.2,3, Vermeire S.4

Created: Wednesday, 20 February 2019, 10:36 AM
P768 Long-term prognosis of Crohn’s disease and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B.D. Ye1, H. Park2, S.H. Kim3, S.N. Hong4, H. Yoon5, Y.J. Kim6, S.I. Seo7, K.H. Rhee8, Y.H. Kim4, K.H. Kim7, J.M. Cha9, S.Y. Park10, S.K. Jeong11, J.S. Kim12, J.P. Im12, J. Jang3, J.H. Kim13, S.O. Suh14, Y.K. Kim15, S.H. Park1, S.K. Yang1, On behalf of the Songpa-Kangdong Inflammatory Bowel Disease (SK-IBD) Study Group

Created: Thursday, 30 January 2020, 10:12 AM
P768: Co-housing DSS treated mice with healthy mice results in faster recovery and normalization of the intestinal microbiota
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Spalinger M.*1, Gottier C.1, Hering L.1, Lang S.1, Rogler G.1,2, Scharl M.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P768: Development and validation of Processed Foods Questionnaire (PFQ) in Israeli adult inflammatory bowel diseases patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Sarbagili-Shabat*1,2, S. Zelber-Sagi1,3, N. Fliss Isakov1, Y. Ron1, A. Hirsh1, N. Maharshak1,2

Created: Friday, 22 February 2019, 9:41 AM
P768: Extended enoxaparin venous thromboembolism prophylaxis after surgery for inflammatory bowel disease: A cost-based decision-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Holubar1*, P. Dulai2, B. Piazik3, S. Finlayson4, B. Udeh5

Created: Thursday, 21 February 2019, 9:14 AM
P768: The prevalence and risk factors for malignancies in patients with inflammatory bowel disease in Crete : a case control study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Foteinogiannopoulou, K.(1)*;Nicolaou, P.(2);Mala, A.(3);Theodoraki, E.(1);Orfanoudaki, E.(1);Theodoropoulou, A.(2);Karmiris, K.(2);Koutroubakis, I.(1);
Created: Friday, 14 July 2023, 11:12 AM
P769 Prevalence and duration of gastrointestinal symptoms in the 10 years before diagnosis of inflammatory bowel disease: A national cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Blackwell1, S. Saxena2, N. Jayasooriya1, I. Petersen3, M. Hotopf4, A. Bottle2, R. Pollok1, POP-IBD

Created: Thursday, 30 January 2020, 10:12 AM